-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
2-(6-Chloro-3-pyridazinyl)-2-phenylacetonitrile, commonly referred to as CB-153932 or nifurtimox, is an organic compound that has been used in various applications in the chemical industry.
In recent years, the use of nifurtimox has been primarily focused on its upstream and downstream products, which are involved in the production of various chemicals and pharmaceuticals.
Upstream Products
One of the primary upstream products of nifurtimox is 3-nitroquinoline-2-carboxylic acid (NQC).
NQC is a precursor in the production of various dyes, pigments, and other chemicals.
It is also used in the production of pharmaceuticals, such as some anti-inflammatory and antiepileptic drugs.
The production of NQC involves the use of nifurtimox as a catalyst in a series of chemical reactions.
Another upstream product of nifurtimox is 2-methylthiazole-4-carboxylic acid (MITC).
MITC is a key intermediate in the production of certain herbicides and pesticides.
It is also used as a catalyst in chemical reactions, such as the production of polyurethanes and other synthetic materials.
The production of MITC involves the use of nifurtimox as a catalyst in chemical reactions that involve the condensation of aromatic and olefinic compounds.
Downstream Products
One of the primary downstream products of nifurtimox is the anti-malarial drug, known as nifurtimox.
Nifurtimox is a combination of two compounds: nifurtimox and eflornithine.
Eflornithine is another organic compound that is used as an antiretroviral drug in the treatment of HIV/AIDS.
Nifurtimox and eflornithine are used together in the treatment of African trypanosomiasis, also known as sleeping sickness.
This disease is caused by parasites that are transmitted through the bite of a tsetse fly.
Nifurtimox is an efficient inhibitor of the parasite's enzyme, transketolase, which is essential for its metabolism.
The combination of nifurtimox and eflornithine has been found to be highly effective in treating African trypanosomiasis.
Another downstream product of nifurtimox is the intermediate chemical, 3-methyl-2-(3-nitroquinoline-2-yl)acrylic acid (MNA).
MNA is used as a building block in the production of various pharmaceuticals, such as some anti-inflammatory and antiepileptic drugs.
MNA is also used in the production of polymer materials and other industrial chemicals.
The production of MNA involves the use of nifurtimox as a catalyst in chemical reactions that involve the condensation of aromatic and olefinic compounds.
In conclusion, 2-(6-Chloro-3-pyridazinyl)-2-phenylacetonitrile, commonly known as nifurtimox, is an organic compound that plays a significant role in the chemical industry.
It is used as a catalyst in the production of upstream products, such as 3-nitroquinoline-2-carboxylic acid (NQC) and 2-methylthiazole-4-carboxylic acid (MITC), which are used as precursors in the production of various chemicals and pharmaceuticals.
Nifurtimox is also used as a building block in the production of downstream products, such as the anti-malarial drug, nifurtimox, and the intermediate